BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/28/2014 9:54:00 AM | Browse: 697 | Download: 765
|
Received |
|
2013-09-29 18:02 |
|
Peer-Review Started |
|
2013-09-30 14:38 |
|
To Make the First Decision |
|
2013-10-22 16:06 |
|
Return for Revision |
|
2013-10-28 12:08 |
|
Revised |
|
2013-11-15 03:38 |
|
Second Decision |
|
2014-01-06 18:19 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2014-01-06 19:00 |
|
Articles in Press |
|
|
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
2014-03-12 13:37 |
|
Typeset the Manuscript |
|
2014-04-17 09:19 |
|
Publish the Manuscript Online |
|
2014-05-14 10:58 |
Category |
Gastroenterology & Hepatology |
Manuscript Type |
Topic Highlights |
Article Title |
Helicobacter pylori: Management in 2013
|
Manuscript Source |
Invited Manuscript |
All Author List |
Yesim Ozen Alahdab and Cem Kalayci |
Funding Agency and Grant Number |
|
Corresponding Author |
Yesim Ozen Alahdab, MD, Department of Gastroenterology and Hepatology, Fatih Sultan Mehmet Education and Research Hospital, E5 Karayolu Uzeri Icerenkoy-Atasehir, 34752 Istanbul, Turkey. yesimalahdab@yahoo.com |
Key Words |
Helicobacter pylori; First-line therapy; Second-line therapy; Rescue therapy |
Core Tip |
Helicobacter pylori (H. pylori) is a prevalent, worldwide, chronic infection. The ideal therapy regimen for H. pylori infection should achieve an eradication rate ≥ 80%. Triple therapy remains an appropriate first-line therapy in areas of low clarithromycin resistance, and quadruple therapy should be the first-line therapy in areas of high clarithromycin resistance. Sequential therapy can be an alternative. Levofloxacin-containing regimens or concomitant therapies can be good choices for second-line therapy. Choice of treatment regimen for H. pylori infection should be done cautiously and antibiotic-resistance rates should be taken into consideration. |
Publish Date |
2014-05-14 10:58 |
Citation |
Alahdab YO, Kalayci C. Helicobacter pylori: Management in 2013. World J Gastroenterol 2014; 20(18): 5302-5307 |
URL |
http://www.wjgnet.com/1007-9327/full/v20/i18/5302.htm |
DOI |
http://dx.doi.org/10.3748/wjg.v20.i18.5302 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345